Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
Vertex Pharmaceuticals, Inc (NASDAQ: VRTX) closed the day trading at $405.27 up 2.01% from the previous closing price of $397.27. In other words, the price has increased by $2.01 from its previous closing price. On the day, 2.2 million shares were traded. VRTX stock price reached its highest trading level at $405.93 during the session, while it also had its lowest trading level at $391.0.
Ratios:
For a better understanding of VRTX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.20 and its Current Ratio is at 2.47. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.11.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on December 20, 2024, Reiterated its Buy rating but revised its target price to $535 from $600 previously.
Jefferies Upgraded its Hold to Buy on December 09, 2024, whereas the target price for the stock was revised from $500 to $550.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 15 ’24 when ALTSHULER DAVID sold 15 shares for $478.56 per share. The transaction valued at 7,178 led to the insider holds 25,813 shares of the business.
ALTSHULER DAVID bought 15 shares of VRTX for $7,178 on Nov 15 ’24. On Nov 11 ’24, another insider, WAGNER CHARLES F JR, who serves as the EVP & Chief Financial Officer of the company, sold 3,000 shares for $518.27 each. As a result, the insider received 1,554,810 and left with 44,137 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VRTX now has a Market Capitalization of 104368775168 and an Enterprise Value of 97558257664. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.85 while its Price-to-Book (P/B) ratio in mrq is 6.68. Its current Enterprise Value per Revenue stands at 9.181 whereas that against EBITDA is 21.94.
Stock Price History:
Over the past 52 weeks, VRTX has reached a high of $519.88, while it has fallen to a 52-week low of $377.85. The 50-Day Moving Average of the stock is -13.63%, while the 200-Day Moving Average is calculated to be -11.44%.
Shares Statistics:
Over the past 3-months, VRTX traded about 1.37M shares per day on average, while over the past 10 days, VRTX traded about 2421160 shares per day. A total of 257.74M shares are outstanding, with a floating share count of 256.90M. Insiders hold about 0.24% of the company’s shares, while institutions hold 92.75% stake in the company. Shares short for VRTX as of 1732838400 were 3671223 with a Short Ratio of 2.68, compared to 1730332800 on 4504708. Therefore, it implies a Short% of Shares Outstanding of 3671223 and a Short% of Float of 1.43.
